Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/24/2014 | CN102441058B 一种养血清脑颗粒的气相色谱指纹图谱检测方法 GC fingerprint detection method Yangxueqingnao particles |
12/24/2014 | CN102429876B 利拉鲁肽缓释微球制剂及其制备方法 Liraglutide release microsphere formulation and preparation method |
12/24/2014 | CN102380359B 一种尺寸均一的分子印迹聚合物纳微球制备方法及应用 One size molecularly imprinted polymer microspheres Carolina uniform preparation method and application |
12/24/2014 | CN102370817B 一种治疗头晕目眩的汤剂药物 A treatment for dizziness drug decoction |
12/24/2014 | CN102342936B 一种氨氯地平和阿托伐他汀钙的药用组合物及其制备方法 One kind of amlodipine and atorvastatin calcium pharmaceutical composition and its preparation method |
12/24/2014 | CN102342930B 硝酸芬替康唑药物组合物 Finland nitrate pharmaceutical compositions for itraconazole |
12/24/2014 | CN102307568B 白藜芦醇组合物 Resveratrol composition |
12/24/2014 | CN102028746B 一种治疗冠心病的药物及提取 Drugs and extract a treatment of coronary heart disease |
12/24/2014 | CN102028743B 一种治疗冠心病的药物及制备 And the preparation of a drug treatment of coronary heart disease |
12/24/2014 | CN101903017B 具有增强的脉冲活性物质释放的包衣的药物或营养制剂 Pharmaceutical or nutritional formulation having enhanced pulse release coat of the active substance |
12/24/2014 | CN101119708B 苯达莫司汀冻干药物组合物 Bendamustine lyophilized pharmaceutical compositions |
12/23/2014 | US8916616 Multi-functional polymeric materials and their uses |
12/23/2014 | US8916606 Therapeutic compositions and methods for targeted delivery of active agents |
12/23/2014 | US8916598 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies |
12/23/2014 | US8916588 Methods for treatment of attention deficit hyperactivity disorder |
12/23/2014 | US8916583 Therapeutic compositions for intranasal administration of zolpidem |
12/23/2014 | US8916566 Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders |
12/23/2014 | US8916562 Methods and compositions for safe and effective treatment of telangiectasia |
12/23/2014 | US8916558 Powders for reconstitution |
12/23/2014 | US8916546 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
12/23/2014 | US8916339 Spinal cord tissue dehydrated and micronized |
12/23/2014 | US8916214 Process for preparing a free-flowing powder containing a deliquescent quaternary ammonium compound |
12/23/2014 | US8916206 Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
12/23/2014 | US8916205 Polymeric nanoparticles for photosensitizers |
12/23/2014 | US8916203 Stable formulations for lyophilizing therapeutic particles |
12/23/2014 | US8916202 Floating microgranules |
12/23/2014 | US8916201 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof |
12/23/2014 | US8916200 Nanoimprint lithography formation of functional nanoparticles using dual release layers |
12/23/2014 | US8916199 Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide |
12/23/2014 | US8916198 Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
12/23/2014 | US8916197 Bone marrow-directing drug delivery materials and their applications |
12/23/2014 | US8916196 Method for the production of emulsion-based microparticles |
12/23/2014 | US8916195 Sustained release formulation of naltrexone |
12/23/2014 | US8916194 Controlled release pharmaceutical compositions of milnacipran |
12/23/2014 | US8916193 Rifaximin complexes |
12/23/2014 | US8916192 Method and apparatus for the preparation of capsules |
12/23/2014 | US8916191 Device for transdermal administration of drugs including acrylic polymers |
12/23/2014 | US8916190 Method of inducing hemostasis in a wound |
12/23/2014 | US8916188 Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block |
12/23/2014 | US8916185 Immobilizing particles onto surfaces |
12/23/2014 | US8916182 Composition comprising oligogalacturonans and polycationic saccharides |
12/23/2014 | US8916171 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis |
12/23/2014 | US8916167 Treatment and diagnosis of macrophage mediated disease |
12/23/2014 | US8916158 Formulation of human antibodies for treating TNF-α associated disorders |
12/23/2014 | US8916157 Formulation of human antibodies for treating TNF-α associated disorders |
12/23/2014 | US8916150 Compositions and methods for enhancing metal ion dependent drug therapies |
12/23/2014 | US8916144 Proangiogenic compositions, method for preparing same, and uses thereof |
12/23/2014 | US8916136 Glucose biosensor system coupled with an anti-inflammatory module and methods for using the same |
12/23/2014 | US8916131 Radiopharmaceutical composition |
12/23/2014 | US8915904 Implantable device with conforming telemetry coil and methods of making same |
12/23/2014 | US8915893 Variable flow infusion pump system |
12/19/2014 | DE202014007438U1 Flüssige Applikation von Verdauungsenzymen Cash and application of digestive enzymes |
12/18/2014 | US20140371692 Hydrogel compositions |
12/18/2014 | US20140371687 Device having titania nanotube membrane for drug delivery |
12/18/2014 | US20140371662 Thermal treatment of the skin surface with metal nanoparticles in surfactant containing solutions |
12/18/2014 | US20140371658 Thermal treatment of acne with metal nanoparticles in surfactant containing solutions |
12/18/2014 | US20140371654 Hair removal with nanoparticles with coatings that facilitate selective removal from the skin surface |
12/18/2014 | US20140371333 Lecithin-organogelling agent |
12/18/2014 | US20140371317 Silicone Resin Emulsions |
12/18/2014 | US20140371309 Ophthalmic solution |
12/18/2014 | US20140371308 Hypotensive lipid-containing biodegradable intraocular implants and related methods |
12/18/2014 | US20140371282 Controlled release pharmaceutical compositions with improved bioavailabililty |
12/18/2014 | US20140371257 Pharmaceutical Formulation Containing Gelling Agent |
12/18/2014 | US20140371197 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
12/18/2014 | US20140371192 Alpha-form zinc-phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an alpha-form zinc-phthalocyanine nanowire/phenothiazine, and method for preparing same |
12/18/2014 | US20140371191 Oromucosal Liquid Estradiol Compositions |
12/18/2014 | US20140371187 Semi-solid delivery vehicle and pharmaceutical compositions |
12/18/2014 | US20140371151 Use of Liposomal WNT Composition to Enhance Osseointegration |
12/18/2014 | US20140370135 Use of extracts of capraria biflora in the prevention and/or treatment of senile cataracts |
12/18/2014 | US20140370123 Skin external composition comprising a sea salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
12/18/2014 | US20140370119 Arsenic Compound Solution and Albumin Nanoparticle and Lyophilized Preparation Entrapping Arsenic Compound Prepared Using Same |
12/18/2014 | US20140370114 Homopolymer nanoparticles by self-emulsion polymerization reaction and preparation method thereof |
12/18/2014 | US20140370113 Hydrocortisone controlled release formulation |
12/18/2014 | US20140370112 Multiparticulate L-Carnitine Compositions and Related Methods |
12/18/2014 | US20140370111 Protein delivery from stem cell microcarriers |
12/18/2014 | US20140370110 Polymer conjugated protein micelles |
12/18/2014 | US20140370109 Stabilized Granules Containing Glyceryl Trinitrate |
12/18/2014 | US20140370107 Multilayer microincapuslated probiotic bacteria |
12/18/2014 | US20140370106 Beadlets comprising hop acid salts in a protein matrix |
12/18/2014 | US20140370104 Pharmaceutical formulation and method for treating acid caused gastrointestinal disorders |
12/18/2014 | US20140370103 Non-immunogenic delivery vehicle for betta-, gamma-, and delta-tocopherols and methods of using and making same |
12/18/2014 | US20140370102 Method and composition for pharmaceutical product |
12/18/2014 | US20140370101 2,2',6,6'-tetraisopropyl-4,4'-biphenol lipid microsphere preparations and preparation methods therefor |
12/18/2014 | US20140370099 Artificial antigen presenting cells having a defined and dynamic shape |
12/18/2014 | US20140370097 Sterile pharmaceutical compositions |
12/18/2014 | US20140370096 Gas transporting rheological medium, end uses and related apparatus-method |
12/18/2014 | US20140370094 Silk-based scaffold platform for engineering tissue constructs |
12/18/2014 | US20140370093 Oral antimicrobial pharmaceutical compositions |
12/18/2014 | US20140370092 Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
12/18/2014 | US20140370091 Method for Producing Aqueous Enteric Coating Liquid, Solid Preparation, and Method for Producing Same |
12/18/2014 | US20140370090 In situ, liquid-activated film coated tablets and a process for making the same |
12/18/2014 | US20140370088 Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
12/18/2014 | US20140370085 Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same |
12/18/2014 | US20140370083 5-aminosalicylic acid capsule formulation |
12/18/2014 | US20140370082 Cyclosporine analogue mixtures and their use as immunomodulating agents |
12/18/2014 | US20140370081 Stable crystal modifications of dotap chloride |
12/18/2014 | US20140370078 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
12/18/2014 | US20140370077 Transdermal drug delivery system containing fentanyl |
12/18/2014 | US20140370076 Transdermal drug delivery system containing donepezil |
12/18/2014 | US20140370069 Methods for treating an established myocardial infarction |